Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Niagen Bioscience, Inc. (NAGE) had Operating Cash Flow per Share of $0.02 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$29.79M |
|
$0.96M |
|
$10.47M |
|
$19.31M |
|
$29.09M |
|
$0.70M |
|
$0.37M |
|
$1.07M |
|
$1.07M |
|
$0.96M |
|
$0.96M |
|
$0.96M |
|
$0.96M |
|
$0.70M |
|
$0.99M |
|
79.32M |
|
82.50M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$97.79M |
|
$1.25M |
|
$8.80M |
|
$106.59M |
|
$15.05M |
|
-- |
|
$9.01M |
|
$24.06M |
|
$82.53M |
|
$77.22M |
|
$82.53M |
|
78.91M |
|
| Cash Flow Statement Financials | |
$1.58M |
|
$5.15M |
|
$-4.78M |
|
$64.79M |
|
$66.74M |
|
$1.95M |
|
$3.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
64.84% |
|
2.35% |
|
2.35% |
|
-- |
|
3.59% |
|
3.23% |
|
$7.23M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
0.51 |
|
3.47 |
|
25.93 |
|
1.17% |
|
1.25% |
|
0.90% |
|
1.17% |
|
$1.05 |
|
$0.09 |
|
|
Operating Cash Flow per Share |
$0.02 |